by Suman Gupta
Bengaluru, February 2018. Anil Kumble, Changing Diabetes® brand ambassador and former captain and coach of the Indian men’s cricket team inaugurated an ‘Insulin Symposium’ organised by Novo Nordisk, a global leader in diabetes care, today at the 73rd Annual Conference of Association of Physicians of India (APICON) in Bengaluru.
The symposium comes on the back of Novo Nordisk’s renewed commitment to educate the physician community on advancements in diabetes treatment. The need for reaching out stems from a strong engagement between the patients and physicians. Usually, physicians are one of the first to diagnose diabetes and can play a key role in improving patients’ diabetes related literacy.
According to IDF Atlas 8th edition, 72.9 million people have diabetes in India and over 58% people have undiagnosed diabetes.
In his opening address at the symposium, Anil Kumble said: “Diabetes in India is on the rise. I am glad that I have the opportunity to be a part of the Changing Diabetes® mission spearheaded by Novo Nordisk India. To manage diabetes, it is essential that one gets timely diagnosis and early initiation of treatment combined with simple lifestyle modifications. As physicians, I urge you to motivate people to recognise the need to know their risk at the earliest for managing diabetes better.”
The workshop conducted by leading city-based diabetologists focused on increasing the participating physicians’ knowledge about the progression of diabetes, the physiological effects of insulin, and tools for successfully initiating insulin in patients with type 2 diabetes. Approximately 300 doctors benefitted from this.
Melvin D’souza, Managing Director, Novo Nordisk India said: “Novo Nordisk is committed towards creating awareness about diabetes and ensuring people with diabetes are provided with best-in-class quality medication. APICON is the right platform for healthcare professionals to congregate and converse on the latest in diabetes care treatment and best practices. We are happy to support API Karnataka Chapter in their endeavour to create a platform to ideate, debate and share scientific updates on diabetes.”
Dr. M. Maiya, Chairman, Organizing Committee APICON 2018 said: “API was established in 1944 with the aim of promoting collaboration, enabling knowledge sharing, advancing treatment practices and skills, and supporting academic endeavour in the field of medicine in India, by conducting its annual national conferences in various cities of India.”
APICON 2018 being held in Bengaluru is one of the largest conferences with the registered delegates tally of around 10,000 The conference featured lectures, interactive workshops and discussions with many prominent and renowned physicians.
About Novo Nordisk : Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 41,700 people in 77 countries and markets its products in more than 165 countries. For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube